애디얼 파머슈티컬(ADIL)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.86 (-3.95%), 시가총액 $5.04M.
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
애디얼 파머슈티컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
애디얼 파머슈티컬의 현재 주가는 $4.86 (-3.95%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
애디얼 파머슈티컬의 시가총액은 약 $5.04M입니다.
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.